DJIA 17,811.28 -3.66 -0.02%
NASDAQ 4,765.26 7.01 0.15%
S&P 500 2,067.39 0.36 0.02%
market minute promo

Vertex Pharmaceuticals (NASDAQ: VRTX)



company name or ticker
Company Photos
(Click to zoom)

PRESS DIGEST - Wall Street Journal

This liver disease could rival hepatitis C

10 stocks to buy if the market keeps dropping

SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Reminds Investors of Class Action Against Vertex Pharmaceuticals Incorporated and Its Board of Directors and a Lead Plaintiff Deadline of July 28, 2014 -- VRTX

INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against Vertex Pharmaceuticals Incorporated

Market for this liver drug could rival hepatitis C

INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against Vertex Pharmaceuticals Incorporated

INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against Vertex Pharmaceuticals Incorporated

INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against Vertex Pharmaceuticals Incorporated

INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against Vertex Pharmaceuticals Incorporated